Chemical formula: C₂₀H₂₁FN₂O Molecular mass: 324.392 g/mol PubChem compound: 146570
Escitalopram is a selective inhibitor of serotonin (5-HT) re-uptake with high affinity for the primary binding site. It also binds to an allosteric site on the serotonin transporter, with a 1000 fold lower affinity.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N06AB10 | Escitalopram | N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AB Selective serotonin reuptake inhibitors |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| CIPRALEX Oral drops, solution | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| CIPRALEX Film-coated tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| LEXAPRO Tablet / Oral solution | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
Escitalopram is an active ingredient of these brands:
United States (US)
Brazil (BR)
Canada (CA)
Croatia (HR)Cyprus (CY)Ecuador (EC)
Estonia (EE)Finland (FI)
France (FR)
Germany (DE)Hong Kong (HK)
Ireland (IE)
Italy (IT)Japan (JP)
Lithuania (LT)Malta (MT)Mexico (MX)
Netherlands (NL)
Poland (PL)
Romania (RO)South Africa (ZA)Spain (ES)Tunisia (TN)Turkey (TR)
United Kingdom (UK)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
